Pentedrone (alpha-methylaminovalerophenone, α-methylaminovalerophenone) is a synthetic stimulant of the cathinone chemical class, structurally related to cathinone and methcathinone through the substitution of the beta-keto carbon chain with a pentanophenone backbone. It is one of the simpler members of the cathinone NPS family and is considered a structural precursor or analog of both A-PVP (which adds a pyrrolidine ring) and hexedrone (which extends the chain by one carbon).
Pentedrone acts as a dopamine and norepinephrine reuptake inhibitor, producing predominantly stimulant effects: energy, focus, mild euphoria, cardiovascular activation, and appetite suppression. It lacks meaningful serotonergic activity, reflecting the absence of methylenedioxy or methoxy ring features associated with SERT activity in this compound class. The subjective experience is characterized as a moderately potent cathinone stimulant — more intense than simple cathinone itself but without the extreme compulsive properties of high-potency pyrrolidine analogs.
Community experience with pentedrone includes Reddit discussions about its analogs — halogenated pentedrone modifications and theoretical synthesis of N-ethylnorpentedrone — reflecting interest in this compound as a structural foundation for further modification. This interest in modification pathways mirrors the broader designer drug research ecosystem that has made pentedrone a structural reference point in the cathinone chemistry literature.
Pentedrone's harm profile is consistent with other moderate-potency NDRI cathinones: cardiovascular stimulation, sleep disruption, compulsive redosing potential, and at high doses or in extended use, anxiety and paranoia. Community accounts of cathinone comedowns apply directly. The absence of meaningful serotonergic activity reduces the serotonin syndrome risk compared to MDxx cathinones, but MAOI combination remains contraindicated due to noradrenergic activity.
Safety at a Glance
High Risk- Test Your Substance
- Reagent testing for cathinone class identification:
- Toxicity: Cardiovascular Effects Dopamine and norepinephrine reuptake inhibition produces sympathomimetic cardiovascular effect...
- Dangerous with: 25x-NBOH, 25x-NBOMe, Atropa belladonna, Datura, MDMA (+3 more)
- Overdose risk: Stimulant overdose from Pentedrone is a medical emergency primarily involving cardiovascular and ...
If someone is in crisis, call 911 or Poison Control: 1-800-222-1222
Dosage
insufflated
oral
Duration
insufflated
Total: 1 hrs – 4 hrsoral
Total: 2 hrs – 6 hrsHow It Feels
Pentedrone arrives with the brisk, businesslike urgency of a cathinone that means to deliver its payload quickly and move on. Within minutes of insufflation, a focused stimulation rises through the body, accompanied by a brief but noticeable rush of euphoria. The heart quickens, attention sharpens, and there is a momentary sense of heightened capability and engagement that feels disproportionately rewarding for its brevity. The nasal burn is moderate, and the characteristic bitter drip appears promptly at the back of the throat.
At its brief peak, lasting roughly thirty to sixty minutes, pentedrone provides a concentrated dose of dopaminergic stimulation. The mind is alert, focused, and driven. There is a desire to accomplish tasks, engage in conversation, or simply move. The euphoria is real but not particularly warm or empathogenic, manifesting more as confidence and energy than as emotional connection. Music sounds slightly better, physical activity feels slightly more fluid, and there is a general sense of things being right with the world that, while modest, is sufficient to make the experience worthwhile in the moment.
Physically, pentedrone follows the standard cathinone template. Elevated heart rate, dilated pupils, suppressed appetite, mild jaw tension, and marginally increased body temperature constitute the expected somatic effects. The physical load is moderate and tolerable for most users. Higher doses amplify the side effects without proportionally enhancing the euphoria, a common pattern among cathinones that encourages restraint in dosing but often fails to achieve it in practice.
The rapid offset of pentedrone's effects is its most consequential feature. Within sixty to ninety minutes, the stimulation has largely dissipated, and what remains is a vague restlessness, a desire for more, and the creeping onset of the comedown. The compulsive redosing potential is moderate to high, driven by the brevity of the positive effects and the unpleasantness of the alternative. The comedown from a single dose is mild: slight fatigue, mild irritability, and a return to baseline without significant distress. After multiple doses, however, the accumulated physical strain and neurochemical depletion produce a more punishing aftermath of fatigue, anhedonia, and restless dissatisfaction.
Subjective Effects
The effects listed below are based on the Subjective Effect Index (SEI), an open research literature based on anecdotal reports and personal analyses. They should be viewed with a healthy degree of skepticism. These effects will not necessarily occur in a predictable or reliable manner, although higher doses are more liable to induce the full spectrum of effects.
Physical Effects
Physical(11)
- Abnormal heartbeat— Abnormal heartbeat (arrhythmia) is any deviation from the heart's normal rhythm — including beats th...
- Appetite suppression— A distinct decrease in hunger and desire to eat, ranging from reduced interest in food to complete d...
- Dehydration— A state of insufficient bodily hydration manifesting as persistent thirst, dry mouth, and physical d...
- Dry mouth— A persistent, uncomfortable reduction in saliva production causing the mouth and throat to feel parc...
- Increased blood pressure— Increased blood pressure (hypertension) is an elevation of arterial pressure above the normal 120/80...
- Increased heart rate— A noticeable acceleration of heartbeat that can range from a subtle awareness of one's pulse to a fo...
- Physical euphoria— An intensely pleasurable bodily sensation that can manifest as waves of warmth, tingling electricity...
- Stimulation— A state of heightened physical and mental energy characterized by increased wakefulness, elevated mo...
- Teeth grinding— An involuntary clenching and rhythmic grinding of the jaw muscles, known clinically as bruxism, that...
- Temporary erectile dysfunction— Temporary erectile dysfunction is the substance-induced inability to achieve or sustain a penile ere...
- Vasoconstriction— A narrowing of blood vessels throughout the body that produces sensations of cold extremities, tingl...
Tactile(1)
- Tactile enhancement— The sense of touch becomes dramatically heightened, making physical contact feel intensely pleasurab...
Cognitive & Perceptual Effects
Cognitive(20)
- Analysis enhancement— A perceived improvement in one's ability to logically deconstruct concepts, recognize patterns, and ...
- Anxiety— Intense feelings of apprehension, worry, and dread that can range from a subtle background unease to...
- Cognitive euphoria— A cognitive and emotional state of intense well-being, elation, happiness, and joy that manifests as...
- Cognitive fatigue— Mental exhaustion and difficulty sustaining thought after intense cognitive experiences, common duri...
- Compulsive redosing— An overwhelming, difficult-to-resist urge to continuously take more of a substance in order to maint...
- Depression— A persistent state of low mood, emotional numbness, hopelessness, and diminished interest or pleasur...
- Disinhibition— A marked reduction in social inhibitions, self-consciousness, and behavioral restraint that manifest...
- Ego inflation— Grandiose overconfidence and inflated self-importance, opposite of ego death, commonly produced by s...
- Empathy enhancement— A state of intensified compassion and emotional openness in which one feels deeply connected to othe...
- Focus enhancement— An enhanced ability to direct and sustain attention on a single task or stimulus with unusual clarit...
- Immersion enhancement— A heightened capacity to become fully absorbed and engrossed in external media such as music, films,...
- Irritability— Irritability is a sustained state of emotional reactivity in which the threshold for annoyance, frus...
- Motivation enhancement— A heightened sense of drive, ambition, and willingness to accomplish tasks, making productive effort...
- Motivation suppression— Motivation suppression is a state of diminished drive and willingness to engage in goal-directed beh...
- Paranoia— Irrational suspicion and belief that others are watching, plotting against, or intending harm toward...
- Psychosis— Psychosis is a serious psychiatric state involving a fundamental break from consensus reality — char...
- Thought acceleration— The experience of thoughts occurring at a dramatically increased rate, as if the mind has been shift...
- Thought deceleration— The experience of thoughts occurring at a markedly reduced pace, as if the mind has been placed into...
- Time distortion— Subjective perception of time becomes dramatically altered — minutes may feel like hours, or hours p...
- Wakefulness— An increased ability to stay awake and alert without the desire to sleep. Distinct from stimulation ...
Pharmacology
Mechanism of Action
Pentedrone's pharmacology has been characterized through a combination of binding studies and analogy with structurally related compounds. It acts as a dopamine and norepinephrine reuptake inhibitor (NDRI), binding to the dopamine transporter (DAT) and norepinephrine transporter (NET) and blocking monoamine reuptake.
As with other simple cathinones, pentedrone is not believed to be a transporter substrate — it does not cause active neurotransmitter release in the manner of amphetamine, but blocks transporter-mediated reuptake.
Structural Relationships
Pentedrone's structure is significant as a pharmacological reference point:
- Relative to methcathinone: Extended alpha-carbon chain (pentanophenone vs. propiophenone backbone)
- Relative to A-PVP: Precursor without the pyrrolidine N-substitution — A-PVP adds a pyrrolidine ring to the same basic scaffold
- Relative to hexedrone: Pentanophenone vs. hexanophenone chain (one fewer carbon)
This structural centrality makes pentedrone a useful reference compound for understanding how structural modifications alter pharmacological activity across the cathinone class.
Serotonin Activity
Like other cathinones without methylenedioxy or methoxy ring features, pentedrone has minimal SERT activity. The experience is therefore predominantly stimulant in character.
Pharmacokinetics
Pentedrone is typically active at doses in the 20–80 mg range. Duration of primary effects is 2–4 hours. Onset via insufflation is approximately 5–15 minutes. The cathinone beta-ketone modification reduces lipophilicity and CNS penetration relative to corresponding amphetamines, contributing to the shorter duration compared to pure amphetamines.
Detection Methods
Standard Drug Panel Inclusion
Pentedrone is a substituted cathinone (synthetic cathinone) that is not included on standard 5-panel or 10-panel immunoassay drug screens. Some extended panels (particularly those marketed for "bath salts" detection) may include cross-reactive antibodies for the cathinone class, but coverage is inconsistent. The structural relationship to amphetamine means some cathinones trigger the amphetamine channel on immunoassays, but this is compound-specific and unreliable for Pentedrone.
Urine Detection
Pentedrone and its metabolites can typically be detected in urine for 2 to 4 days following a single dose. Repeated or binge-pattern use may extend this window to 5 or more days. Primary metabolic pathways involve reduction of the beta-keto group, N-dealkylation, and hydroxylation. The resulting metabolites are excreted renally, often as glucuronide or sulfate conjugates.
Blood and Saliva Detection
Blood detection windows for Pentedrone range from 12 to 48 hours depending on dose and individual metabolism. Plasma concentrations decline rapidly due to extensive distribution into tissues. Oral fluid testing can detect Pentedrone for approximately 24 to 48 hours but is not commonly deployed for synthetic cathinones outside of specialized forensic settings.
Hair Follicle Detection
Hair analysis can detect synthetic cathinones including Pentedrone for up to 90 days. Incorporation into the hair shaft follows standard pharmacokinetic principles for basic amines. However, most commercial hair testing panels do not specifically target Pentedrone, requiring custom LC-MS/MS methods with appropriate reference standards.
Confirmatory Testing
Definitive identification of Pentedrone requires instrumental analysis. Liquid chromatography-tandem mass spectrometry (LC-MS/MS) is the preferred method for synthetic cathinones due to their thermal lability, which can cause degradation during gas chromatography. GC-MS remains usable but may require derivatization for optimal sensitivity. Reference standards specific to Pentedrone are necessary for quantitative confirmation.
Reagent Testing
Marquis reagent typically produces no reaction or a faint yellow-orange color with Pentedrone. Mecke reagent may show no significant color change. Mandelin reagent can produce a yellow to brown reaction. The lack of strong, characteristic color reactions with common reagents makes cathinone identification by reagent testing alone unreliable. A combination of Marquis, Mecke, Mandelin, and Simon's reagents can help rule out other substance classes but cannot positively confirm Pentedrone.
Interactions
| Substance | Status | Note |
|---|---|---|
| 25x-NBOH | Dangerous | — |
| 25x-NBOMe | Dangerous | — |
| Atropa belladonna | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| Datura | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| Diphenhydramine | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| Harmala alkaloid | Dangerous | Risk of hypertensive crisis and serotonin syndrome; potentially fatal combination |
| Peganum harmala | Dangerous | Risk of hypertensive crisis and serotonin syndrome; potentially fatal combination |
| MDMA | Unsafe | — |
| 1,3-Butanediol | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| 25E-NBOH | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| 2C-T | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| 2C-T-2 | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| 2C-T-21 | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| Alcohol | Uncertain | — |
| Dissociatives | Uncertain | — |
History
Chemical Origins
Pentedrone represents the cathinone-class stimulant equivalent of a moderately elongated alpha-carbon side chain, developed within the systematic exploration of cathinone structure-activity relationships that characterized the NPS market. Its pentanophenone backbone was a natural extension of the propiophenone (methcathinone) and butanophenone scaffolds.
NPS Market History
Pentedrone appeared in European drug markets and early warning systems in the early 2010s as the cathinone NPS wave continued to expand. It was documented in forensic analyses and drug seizure reports across multiple countries.
Structural Significance
Pentedrone's structural position as the precursor scaffold for A-PVP (through cyclization to form the pyrrolidine ring) and as a homolog of hexedrone makes it pharmacologically significant beyond its own use profile. Understanding pentedrone's pharmacology provides a baseline for understanding the effects of structural modifications.
Regulatory Status
Pentedrone is controlled in numerous jurisdictions through explicit scheduling, cathinone-class legislation, or analog laws. UK, EU member states, and many other countries have implemented controls.
Harm Reduction
Test Your Substance
Reagent testing for cathinone class identification:
- Mecke and Marquis reagents
- Fentanyl test strips
Dose Carefully
Start with the lowest effective dose; use a milligram-accurate scale. Pentedrone's potency is moderate but not trivial.
Avoid Compulsive Redosing
The 2–4 hour duration and dopaminergic mechanism create conditions for redosing. Set dose limits in advance.
Avoid MAOI Combination
MAOIs are contraindicated with pentedrone due to noradrenergic activity — risk of hypertensive crisis.
Structural Analogs and Research
Community interest in pentedrone analogs (halogenated variants, N-ethylnorpentedrone) reflects the compound's role as a structural reference. Users exploring modifications should be aware that structural analogs can have dramatically different potency and risk profiles — predicting effects from structure alone is unreliable.
Dangerous Combinations
- MAOIs: Contraindicated
- Other stimulants: Additive cardiovascular risk
- Alcohol: Masks warning signs
Toxicity & Safety
Cardiovascular Effects
Dopamine and norepinephrine reuptake inhibition produces sympathomimetic cardiovascular effects: elevated heart rate and blood pressure, peripheral vasoconstriction. These are dose-dependent and represent real risk for individuals with cardiovascular conditions.
Compulsive Use
The dopaminergic NDRI mechanism carries inherent compulsive redosing potential. While pentedrone is likely less compulsively driven than high-potency pyrrolidine analogs, the cathinone mechanism creates conditions for escalating use, particularly with the 2–4 hour duration profile.
Anxiety and Psychiatric Effects
High doses may produce anxiety, agitation, and at extremes stimulant-induced paranoia. Extended binge use can produce stimulant psychosis, though this is more characteristic of higher-potency cathinones.
Drug Interactions
- MAOIs: Contraindicated — hypertensive crisis risk via noradrenergic mechanism
- Other stimulants: Additive cardiovascular effects
- Alcohol: Masks warning signs
Unknown Chronic Effects
Long-term neurotoxicity data for pentedrone specifically is not available. The cathinone class in general lacks comprehensive long-term safety characterization.
Addiction Potential
moderately addictive with a high potential for abuse
Overdose Information
Stimulant overdose from Pentedrone is a medical emergency primarily involving cardiovascular and neurological toxicity.
Signs of overdose: Extremely rapid or irregular heartbeat, chest pain, severe headache, dangerously elevated body temperature, seizures, agitation progressing to psychosis, confusion, and loss of consciousness.
Emergency response:
- Call emergency services immediately
- Keep the person cool (remove excess clothing, apply cool water)
- If seizures occur, protect the head and clear the area of hard objects
- If the person loses consciousness, place in recovery position
- Do not give the person more stimulants, caffeine, or depressants unless directed by medical professionals
Prevention: Pre-measure doses. Avoid redosing. Stay hydrated (but don't overhydrate). Take breaks from physical activity. Monitor heart rate if possible. Have someone present who can recognize warning signs.
Dangerous Interactions
The combinations listed below may be life-threatening. Independent research should always be conducted to ensure safety when combining substances.
Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Risk of hypertensive crisis and serotonin syndrome; potentially fatal combination
Risk of hypertensive crisis and serotonin syndrome; potentially fatal combination
Tolerance
| Full | develops with prolonged and repeated use |
| Half | 3 - 7 days |
| Zero | 1 - 2 weeks |
Cross-tolerances
Legal Status
Brazil: Possession, production and sale is illegal as it is listed on Portaria SVS/MS nº 344.
China: As of October 2015, pentedrone is a controlled substance in China.
Czech Republic: Pentedrone is banned in the Czech Republic.
Germany: Pentedrone is controlled under Anlage II BtMG (Narcotics Act, Schedule II) as of July 17, 2013. It is illegal to manufacture, possess, import, export, buy, sell, procure or dispense it without a license.
Switzerland: Pentedrone is a controlled substance specifically named under Verzeichnis D.
Turkey:** Pentedrone is a classed as drug and is illegal to possess, produce, supply, or import.
The Netherlands:** Pentedrone is currently legal, but it is part of a substance group that may be banned soon as part of a recently passed law on New Psychoactive Substances (NPS).
United Kingdom: Pentedrone is a Class B drug in the United Kingdom as a result of the cathinone catch-all clause.
United States: On January 28, 2014, the DEA listed it, along with 9 other synthetic cathinones, on the Schedule 1 with a temporary ban, effective February 27, 2014.
Responsible use
Designer drug
Psychoactive substance index
Stimulant
Substituted cathinone
N-Ethylpentedrone (NEP)
Pentedrone (Wikipedia)
Pentedrone (Isomer Design)
Pentedrone (Forum)
Simmler, L. D., Rickli, A., Hoener, M. C., & Liechti, M. E. (2014). Neuropharmacology Monoamine transporter and receptor interaction profiles of a new series of designer cathinones. Neuropharmacology, 79, 152–160. https://doi.org/10.1016/j.neuropharm.2013.11.008
Hwang, J., Kim, J., Oh, J., Hong, S., Ma, S., Jung, Y., … Jang, C. (2014). The new stimulant designer compound pentedrone exhibits rewarding properties and affects dopaminergic activity, 117–128. https://doi.org/10.1111/adb.12299
Experience Reports (3)
Tips (8)
Start low with Pentedrone and wait for full onset before redosing. Stimulant redosing extends duration and side effects more than it extends euphoria, while adding cardiovascular strain. Set a firm limit before you start.
Avoid binge patterns with Pentedrone. Sleep deprivation combined with stimulant use dramatically increases psychosis risk after 48+ hours awake. If you find yourself redosing to avoid the comedown, that is a major warning sign.
Eat a substantial meal before taking Pentedrone. Stimulants suppress appetite heavily, and going many hours without food leads to worse crashes, irritability, and cognitive impairment. Set phone reminders to eat and drink.
4-Chloro-pentedrone (4-CPD) is extremely new to the market with virtually no published safety data or user reports. Halogenated cathinones may have unpredictable toxicity profiles. If you choose to research this compound, use allergy-test doses first and do not combine with other stimulants.
Have a landing plan for the Pentedrone comedown. Prepare food, melatonin or magnesium, and a comfortable environment in advance. Avoid using depressants to manage the comedown as this creates polydrug dependency patterns.
N-Ethyl-Pentedrone (NEP) is the N-ethyl analogue of pentedrone and is considered more recreational than the parent compound. It produces stronger euphoria and empathogenic effects. However, the compulsive redosing potential is high and the comedown can be harsh.
Community Discussions (2)
See Also
References (4)
- Amphetamine: new content for an old topic — Heal et al. Neuropsychopharmacology Reviews (2013)paper
- PubChem: Pentedrone
PubChem compound page for Pentedrone (CID: 57501499)
pubchem - Pentedrone - TripSit Factsheet
TripSit factsheet for Pentedrone
tripsit - Pentedrone - Wikipedia
Wikipedia article on Pentedrone
wikipedia